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ABSTRACT 
Introduction: Tuberculosis (TB) is a major cause of morbidity and mortality worldwide 
especially in developing countries like Ethiopia. Tuberculosis treatment outcome is one 
of the important issues to reduce this high mortality and morbidity.  
Objective:The goal of this research is to assess TB treatment outcome and its 
associated factors among TB patients attending in Bahir Dar town governmental health 
institutions. 
Methods: A five years retrospectivefollow study wasconducted among TB patients in 
Bahir Dar town governmental health institutions.Among ten health centers four health 
centers were  selected by using multi stage sampling technique and one hospital  was 
taken thenSimple random sampling technique was used to select the registered 
patients. Structured checklistwas used to collect the data from the TB registration book. 
Training was given for two data collectors and close supervision was made by the 
principal investigator. Data were entered in to EPI Info and exported toSPSS version 20 
software for analysis. Descriptive statistics was used to summarize the data.  Bivariate 
and Multivariate logistic regression model were used.  Crude and Adjusted odds ratio 
with 95% CI interval were used to assess the strength of association between the 
outcome and independent variables.  
Result:A total of 416 TB patients were participated in the study.  More than half 240 
(57.5 %) of the participants were males and two third 284 (68.3%) were urban dwellers. 
The mean age of the participants was 28.55 (SD14.9) years. Poor TB treatment 
outcome was 41 (9.9%) (95% CI: 7.0, 13.1%). Out of patients with poor 
outcome,28(68.3%) were died, 9 (22.0%) had treatmentfailure and 4 (9.8%) were loss 
to follow up.HIV positive TB patients were (AOR=5.1 (95% CI: 2.6, 10.1) significantly 
associated with poor treatment outcome.  
Conclusion and Recommendation:Poor TB treatment outcome among TB patients was 
found to be high. HIV status was identified to be the associated factors for poor TB 
treatment outcome. Hence, special attention has to be given for TB/HIV co-infected 
patients to enhance good treatment outcome. 
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1.INTRODUCTION 
1.1. Statement of the problem 
Tuberculosis is a chronic mycobacterial infection present in all parts of the world. It 
remains one of the world’s deadliest communicable diseases[1]. 
TB remains a major global health problem, responsible for ill health among millions of 
people each year. TB ranks as the second leading cause of death from an infectious 
disease worldwide, after the human immunodeficiency virus (HIV). The latest estimates 
included in 2014 WHO report are that there were 9.0 million new TB cases in 2013 and 
1.5 million TB deaths (1.1 million among HIV-negative people and 0.4 million among 
HIV-positive people). In 2013, an estimated 9.0 million people developed TB and 1.5 
million died from the disease[2]. To detect the disease asearly as possible is very 
important to control TB and to ensure that those diagnosed completetheir treatment and 
get cured[3]. The highest incidence and  death of TB occur in developing countries like 
Asia and east Africa[4]. 
According to the World Health Organization (WHO), treatment outcome is an important 
indicator for tuberculosis (TB) prevention and control program. Therefore, treatment 
plans that emphasize directly Observed Treatments (DOTS) for at risk patients have the 
greatest success (96.5%) in improving tuberculosis treatment outcome in the region.  
Without treatment, TB mortality rates are high. In studies of the natural history of the 
disease among sputum smear-positive/HIV-negative cases of pulmonary TB, around 
70% died within 10 years; among culture-positive (but smear-negative) cases, 20% died 
within 10 years[1]. 
WHO 2014 report mention that the treatment success rate among new cases of TB 
continues to be high (86%), but major efforts are needed to ensure all cases are 
detected, notified and treated[2]. Even where free medication is available, many 
patients are not successfully treated for TB. [5, 6].  Incomplete treatment may result in 
an extended period of infection, TB resistance to treatment, and lead to increased  
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morbidity and mortality [7]. For the year 2005, the WHO target for treatment success 
was 85% [4]. 
Ideally, treatment outcome in all patients should be routinely monitored by the 
epidemiological surveillance system. Until now, very few studies have been done on 
treatmentoutcomes of TB in Ethiopia[8-10]. Previous Ethiopia tuberculosis survey 
showed that an annual risk of infection of TB is  ranged from 1.4% to 3.0% [11-13]. 
Therefore, TB has been recognized as major public health problem in Ethiopia for more 
than half a century ago. The effort to control TB began in the early 1960s with the 
establishment of TB centers and  in three major urban areas in the country namely 
Addis Ababa, Asmara, and Harar.  
 
The limitation is that previous TB researches focused on reports collected from Sub-
cityhealth offices of the city and subsequently reported to the Federal Ministry of Health, 
focusing on hospitals. This researchwas used TB patient record register data in the 
health centers todetermine the factors for treatment success. The aim of thestudy is to 
assess treatment outcome and associated factors of TB patientsand assess the 
association of demographic, disease category, disease classification and co-morbidity 
with poor treatment outcome of patients in Bahir Dar town, Amhara National Regional 
State, Ethiopia 
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1.2. Literature review 
Tuberculosis treatment outcome 
Treatment outcomes are classified as good (cure/completed) or poor (loss to follow 
up/failure/death). Successful treatment of tuberculosis (TB) involves taking anti-
tuberculosis drugs for at least six months.  Various studies showed that TB treatment 
outcome is vary in different setups. In a study carried out in Brazil, the overall treatment 
loss to follow up ratio was 20.9% and the unsuccessful outcome rate was 24.1% [7].  
Retrospective audit of patients registered from TB treatment centers in southern 
Ethiopia showed that 74.8% had a successful and16.7% a poor treatment outcome. Of 
those with a poor outcome, 60.9% patients defaulted, 36.9% died and 2.2% failed 
treatment ([14]).Poor treatment outcome occurred in 25.3% of children aged <5 years, 
12.9% of 5–9-year-olds and 9.3% of 10–14-years old (P < 0.001). Similar study in the 
same setup showed that 8.9% TB treated patients were died during the TB treatment 
course([15]). Transferred-in patients were more likely to default (19.4%) than patients 
on retreatment (13.5%) or new cases (10.6%, P = 0.004). Patients from urban areas 
were more likely to default than patients from rural areas (12.6% vs. 8.8%, P < 0.001) 
Patients residing in urban areas had poorer treatment outcome than patients from rural 
areas (20.9% vs. 14.1%, P < 0.001), and treatment .[15] 
 
a retrospective study in six randomly selected health centers in Addis Ababa, Ethiopia 
showed that 12.71% TB treated patients were died during the study period([16]. Another 
register based historical cohort study done in Addis Ababa showed that 18.1% were 
reported as being cured, 64.6% were documented as treatment completed, 3.7% died 
during follow-up, 5.1% were reported as defaulters, 0.4% were documented as 
treatment failure and 8.2% were transferred out to another health institution ([17]). 
A study conducted in University of Gondar Hospital, TB Directly Observed Treatment 
Short Course (DOTS) clinic showed that the overall treatment outcome was  cured in 36 
(19.9%), completed in 91 (50.3%), defaulted in 9 (5%), failed in 3 (1.7%), died in 1 
(0.6%), and transferred out in 41 (22.7%) of the cases [18] 
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A five-year retrospective follow up study at Enfraz Health Center, Northwest Ethiopia 
reveled that treatment outcome of tuberculosis patients379 (94.8%) had successful 
treatment outcome (302 treatment completed and 77 cured). And in this study the 
overall death, default, and failure rates were 3.4%, 0.5%, and 1.2%, respectively[19]. 
1.2.1. Factor associated with TB treatment out come 
Many factors may lead to poor completion rates of TB treatment.It appears that 
treatment outcomes for TB patients are an indication of the quality of care they receive. 
various studies showed that TB treatment outcome is associated with  personal, socio-
economic and behavior factors[ 21].  
Study done in Nigeria showed that the probability of developing TB is much higher 
among people infected with HIV. TB is also more common among men than women, 
and affects mainly adults in the most economically productive age groups[ 22]]. 
Study done in Nigeria  showed that year of treatment and treatment center were factors 
associated with treatment success ([22, 23]). In the bivariate analysis, age between 35 
and 44 years and ≥65 years showed statistically significant association with 
unsuccessful treatment outcome as compared to patients aged between 15 and 24 
years. The multiple logistic regression showed no significant association between 
unsuccessfultreatment outcome and the different characteristics of the TBpatients 
including age, sex, residence, and HIV status. 
 
A retrospectively study analyzed the clinical records of HIV-negative TB Patients with 
culture-proven MDR- or XDR-TB at five large-scale Tuberculosis Specialized Hospitals 
in China showed that poor outcomes were associated with duration of previous anti-TB 
treatment of more than one year([24]).  
 
Study conducted to assess the factors affecting treatment outcomes of tuberculosis in a 
Tertiary Health Center in Southwestern Nigeria revealed the  factors that affect the 
Tuberculosis outcome negatively were smear positive (+)status at diagnosis, failure to 
give consent for HIV test and HIV co-infection[25]. 
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Figure 2: Conceptual framework of TB treatment outcome and associated factors in 
Governmental health institution. 
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1.5. Justification of the study 
Despite high DOTS coverage in Ethiopia in  Amhara region,there is only little 
information about factors responsible for poor treatment outcome in the area. By 
assessing the TB treatment outcome of the patients, this study gives an important 
insight on the performance of the TB programs in the region. Policy makers, clinicians 
and stakeholders could use the result of the study to make informed decision in the 
prevention and control of MDR - TB which is a result of poorly performing DOTs 
program.This study has also tried to assess the associated factors for poor treatment 
outcome so as to help evidence based interventions and highlight on possible risk 
factors to be investigated further in subsequent studies. 
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2. Objectives 
2.1. General objective 
 
To assess tuberculosis treatment out come and associated factors among TB patients 
in governmental health institutions in Bahir-dar town.  
 
2.2. Specific objectives: 
 
To determineTB treatment outcome among TB patients attending inBahir-dar town 
governmental health institutions, Northwest Ethiopia 
To identify associated factors of TB treatment outcome in Bahir-dar town governmental 
health institutions., Northwest Ethiopia 
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3. Methods 
 
3.1. Studydesign and study period 
A retrospective follow-up study was used on a fiveyear registered data from May to 
June 2015. 
3.2.Study area 
The study conducted in Bahir Dartown governmental health institutions.Bahir-dar town 
is the capital city of Amhara National Regional State, 565 km away from Addis Ababa.  
In the town there is one referral hospital and 10 health centers (6 urban and 4 rural 
health centers). The health institutes in the study area have diagnostic facilities for TB 
including microscopic examination of sputum for acid-fast bacilli.  Moreoverx-ray 
examinationand pathology examination services are also accessible in a reasonable 
distance for most of the centers. 
3.3. Source and Study population 
The source populations for this study was all TB patients attendedin Bahir Dar 
towngovernmental health institutions and the study populations was all TB patients 
attended in Bahir Dar townin the selected governmental health institutions from Sept. 
2011 to June 2015 G.C.  
3.4. Inclusion and Exclusion criteria 
 Inclusion criteria 
All TB patientswho attended TB treatment follow up at least for one month 
ingovernmental health institutionin Bahir-Dar town from May 2011 to June2015 G.C.   
Exclusioncriteria 
Whowere transferred out to other health institution; and all TB patients with incomplete 
information  regarding the treatment outcome in registration books were excluded from 
this study.  
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3.5. Sample size and sampling procedures 
. Sample Size Determination 
Objective 1 
Single population proportion formula was used to determine the sample size for TB 
treatment outcome by considering the following assumptions: Margin of  error(0.05), 
95% CI(Z(a/2) = 1.96) and proportion poor treatment outcome taken from a study done 
in southern Ethiopia(p = 16%)  
           n = z (a/2)2 p( 1-p ) 
                             d2 
n =  (1.96)2 x 0.16 x 0.84 
 (0.05) 2 
n = 206 
The calculated sample size was 206and considering the design effect and multiplied by 
2 the final sample was 412.  
Objective 2 
The sample size was also calculated by using double population proportion formula for 
the second objective by taking age as a factors, which was reported from a study 
conducted in the Southern Region of Ethiopia,Hawassaon poor treatment outcome[15].  
Major factor  Assumption    OR Sample size 
Age 
(24-34, 
 10-14) 
 
At 95% of CI and 80% 
power  
 
2.36 
(19.4%, 9.3%) 
 
416 
 
To take the maximum sample size the second value was take and the total sample 
sizeconsidered in this study was 416. 
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Sampling Procedures 
Sampling technique  
Multistage sampling technique was used. First four health center among ten  health 
centers and one hospital were selected. Then the study participants selected from list of 
patients in the five years registration book using simple random sampling lottery 
technique. The numbers of participants taken from each health institution Hospital, Han, 
Kebele11 , Zegie,  Zenzelma health centers (584,935,555,136,126 participants 
respectively ) were considered proportionally. 
3.6. Variables of the study 
Dependent Variable 
TB treatment outcome (Poor/Good) 
Independent Variables
 Socio demographic variables (Age, Sex, Residence) 
 patient category 
 Disease   classification 
 Co-morbidities ( HIV) 
 site o f health  institution( Rural,Urban) 
 Drug in continuation phase  (EH , RH, (RH)E) 
 Health center( urban, rural ) 
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3.7. Operational definitions 
Good TB treatment outcome:cured or completed  
Poor TB treatment outcome: failure or loss to follow up or death 
Cured:Patient who is smear negative at or one month prior to, the completion of treatment 
and at least one previous occasion 
Treatment completed: Patient who has completed treatment but whom smear results are not 
available on at least two occasions prior to completion of treatment.  
Treatment failure:Patient who remains or becomes again smear positive at 5 months or later 
during treatment.  
Loss to follow up: Patient whose treatment was interrupted for at least 2 months.  
Died:Patient who dies for any reason during treatment.  
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3.8. Data collection procedures and data quality control 
A structure checklist which has been developed after reviewing of relevant literature was 
used to collect the data. The checklist was pretested on the TB registered book to see the 
availability of the variables and its familiarity to fill the data easily. Then careful modification 
of the checklist   was done. The data were collected on the patient’s five years registered 
book by trained health professional. Prior to data collectiontwo hours training was given for 
the data collectors on the objective of the study, checklist and on how to collect the datafrom 
patients’ registration. The collected data were checkedby the principal investigator and 
missing questioner were checked daily.  
3.9. Dataprocessing and Analysis 
The data were coded and entered in to EPI Info reversion 3.5.3 then exported to SPSS 
version 20 software for cleaning and analysis. Descriptive statistics like mean, standard 
deviation and proportion were performed. Bivariate and Multivariate binary logistic regression 
model were used. Variable having p-value less than 0.05 in the multivariate model were 
considered to be significant. Crude odds ratio(COR) and Adjusted Odds ratio (AOR) with 
95% Confidence Interval(CI) were calculated to indentified those explanatory variables which 
have association with the outcome variables.  
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4. Ethical Considerations 
Ethical approval was obtained from Institutional Review Board of the College of Medicine 
and Health Sciences, University of Gondar.  Then permission was obtained from Bahir-dar 
Governmental health institutions after informing about the objective of the study througha 
support letter from Gondar University. Oral consent was obtained from those health 
professionals working in the DOT clinics. The collected information was mentioned 
confidentially.   
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5. Dissemination of Results 
The findings of this study will be submitted to University of Gondar, , Amhara National 
Regional State Health Bureau, Bahir Dar town governmental and nongovernmental health 
institutions,so that the recommended solutions will be put in to action in a desired and 
designed manner.The study can be presented in various meetings, seminars and 
workshops. Attempt will be also made to publish in a peer reviewed scientific journal. 
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6.  RESULTS 
 
Socio-demographic and clinical characteristics of participants 
A total of 416 TB patients participated in the study.   More than half 240(57.5 %) of the 
participants were males and two third 284 (68.3%) were urban 
The largest number of the participants, 194(46.6%) were less than 24 years old and the 
mean age of participants was 28.55 (SD14.9)years.  Almost half 216 (51.9%) of the study 
participates were diagnosedwith Extra Pulmonary Tuberculosis (PTB) and 133 (32 %)were 
pulmonary negative patients.  Seventy four (17.8 %) had HIV co-infectionand one fourth 102 
(24.5 %) of the patients used Ethambutol with isoniazid. Almost three fourthof the patient 
was attended in the health center(76.9%)and started their medication in the first six 
months(71.2%) (Table1). 
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Table 1.Socio -demographic and clinical characteristics of TBpatients in Bahir 
Dar town governmental health institutions , June 2015.  
 
Variables frequency percentage 
Sex 
Male 
Female 
 
240 
176 
 
57.7 
42.3 
Age (year) 
0-24 
25-34 
35-44 
>45 
 
194 
99 
61 
62 
 
46.6 
23.8 
14.7 
14.9 
Residence 
Urban 
Rural 
 
284 
132 
 
68.3 
31.7 
Patient category  
New  
Relapse  
Failure 
Default/loss to follow up 
 
404 
6 
2 
4 
 
97.1 
1.4 
0.5 
1.0 
Disease classification 
Pulmonary positive TB 
Pulmonary negative TB 
Extra pulmonary TB 
 
67 
133 
216 
 
16.1 
32 
51.9 
HIV status  
Reactive 
Non-reactive 
unknown 
 
74 
320 
22 
 
17.8 
76.9 
5.3 
Drug in continuation phase 
EH 
RH  
(RH)E 
 
102 
309 
5 
 
24.5 
74.3 
  1.2 
Health institution 
           Health center 
           Hospital 
 
                 320 
                   96 
 
             76.9 
             23.1 
Drug starting month 
Tsedey 
Meker 
Belig 
Kiremt 
 
                 143 
                 153 
                    69 
                    51 
 
               34.4 
               36.8 
               16.6  
                12.3          
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Treatment outcome of TB patients 
In this study, 9.9% (95% CI: 7.0, 13.1%)of the TB treated patients had poor treatment out-
come. And out of patients with poor outcome,28(68.3%) them were died, 9 (22.0%) 
werefailure and 4 (9.8%) were loss to follow up.From the total study participants, 53 (12.7%) 
of them were cured and majority of 322 (77.4%) them were treatment completed figure 1. 
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Figure1. Treatmentoutcomes of TB patients in Bahir Dar town governmental health institution, 
June 2015. 
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Factors associated with TB treatment outcome 
In the Bivariate analysis, age, disease classification, patient category and HIV status were 
significantly associated with treatment outcome of tuberculosis.  
In the multivariate analysis, HIV status variable was remaining significantly associated with 
TB treatment outcome. Those HIV positive TB patients were five times (AOR=5.1 (95% CI: 
2.6, 10.1) more likely to develop poor treatment outcome as compared to those non-reactive 
and un-known HIV status TB patients (Table 3).  
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Table :-2 Bivariate and multivariable analysis of factors associated with 
treatment outcome of tuberculosis patients in Bahir Dar town health institutions, 
ANRS, Northwest Ethiopia, June 2015 (n=416) 
 
Variable 
Treatment outcome  
 
COR(95% CI) 
 
 
AOR(95 % CI) 
Good poor 
Sex 
Male 
Female 
 
211 
164 
 
  29 
12 
 
1.88  (0.9-3.8 ) 
1 
 
Age(years) 
0-24 
        25-34 
        35-44 
>45 
 
182 
90 
50 
53 
 
12 
9 
11 
9 
 
1 
1.52(0.6,3.7 ) 
  3.34 (1.4, 8.0) 
2.58(1.0,6.4 ) 
 
Residence 
Urban 
Rural 
 
256 
119 
 
28 
13 
 
1.00(0.5, 2) 
1 
 
Health institution  
Health center   
Hospital  
 
289 
86 
 
     31 
     10 
 
0.92 (0.5, 2.0) 
1.00 
 
Patient category 
                 New 
                 Previously treated                                                                                                                                            
 
366 
9
 
38 
3
 
1 
0.31(0.1,1.2) 
 
Disease classification 
Pulmonary positive TB 
            Pulmonary negative TB  
            Extra pulmonary TB 
 
55 
125 
195 
 
12 
8 
21 
 
2.03 ( 0.9, 4.4 ) 
0.59 (0.3 , 1.4) 
1 
 
HIV status 
Reactive 
              Non-reactive/un-known 
 
55 
320 
 
19 
22 
 
5.02 (2.6,9.9) 
1 
 
5.1 (2.6,10.1 ) 
1 
drug in continuation phase 
EH 
               RH / (RH)E 
 
89 
286 
 
13 
28 
 
1.49 ( 0.8 – 3.0 ) 
1 
 
 
 
   Treatment started  month1       
Tsede 
Meker 
Belig /Kiremt 
 
     124 
 
138 
 
       113 
 
   19 
 
15 
 
7 
 
2.47(1.0,6.1) 
 
1.76(0.7,4.5) 
 
1 
 
 
Health institution 
                 Health center 
                 hospital 
 
      289 
       86 
 
31 
    10 
 
1 
1.08 (0.5, 2.3 ) 
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7. DISCUSSION 
 
In this study, 9.9% TB treated patients had a poor treatment outcome which is similar with 
study done in Southern Ethiopia (8.9%) and Northwest Ethiopia, University of Gondar ([26]. It 
is also similar with a retrospective study in six randomly selected health centers in Addis 
Ababa, Ethiopia (12.71%)([27]).  
 
However, itis lower thanthe research done in southern region of Ethiopia,Hawassa (16.7%) 
from 2002 to 2007 GC[15] and Addis Ababa, Ethiopia (17.3 %) from 2009 to 2010.[17], 
University of Gondar  students in Northwest Ethiopia (29.2% )from 2007 to  2011[18], 
Southwestern Nigeria,(53.9%) in year 2010[22].  
This discrepancy could be due to the difference in the time period in which all the above 
research has been conducted before 2011. The infrastructure and health care accesses is 
relatively improved from time to time.  This difference could be also due to the fact that the 
previous   DOTS Strategy requires that the patient be treated for eight months which 
includes a two months intensive phase in which treatment was  given under strict supervision 
by a trained health professionals,  and a six month continuation phase monthly follow up  
was applied. In addition the drug used in continuation phase was EH.The current   DOTS 
Strategy requires that the patient be treated for six months which have 2 months intensive 
phase, and a four months continuation phase in which treatment is given under strict 
supervision by a trained health professional throughoutthe treatment period and the drug 
used in continuation phase is RH.Sothe long duration of treatment and monthly follow up in 
the continuation phase may increase the poor treatment outcome and the other reason could 
be due to drug difference. 
But poor treatment outcome is higher insouthern region of Ethiopia,Hawassa ,Addis Ababa, 
EthiopiaUniversity of Gondar  students, in Northwest Ethiopia  and Southwestern Nigeria 
compared to a five-year retrospective follow up study at Enfraz Health Center, Northwest 
Ethiopia in which poor treatment outcome of tuberculosis patients was 5.2% [19].This 
difference could be fact that the previous study was conducted only in one health centers 
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where our study was conducted in four health centers and one hospital. There could be a 
difference in patient care between overcrowded hospitals like Felege Howit referral hospital 
than health centers.  
 
HIV status was identified to be associated of poor TB treatment outcome.Those HIV positive 
TB patients were five times more likely to develop poor treatment outcome as compared to 
those non-reactive or un-known HIV status TB patients. This finding is also supported by 
other study conducted in Southwestern Nigeria ([22]). The reason may be due to drug 
interaction, drug side effect or complication, pill burden, impact of HIV like hopeless feeling, 
depression, and dementia among those HIV infected patients.  
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8. STRENGTH   AND  LIMITATION OF THE STUDY 
 
The study was conductedfrom  a five years data and include five health institutions 
Since the study was based on secondary data, all necessary variables like behavioral 
and socio-economic factors  which have been identified as a significant factors for poor 
treatment outcome in other study were not include in this study.  
This study considered all type of death actually which may not be due to TB was as 
poor treatment outcome as it was difficult to ascertain the cause of death in the 
secondary data. 
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9. Conclusion 
 Poor TB treatment outcome among TB patients attending in Bahir-dar town 
governmental health institutions was found to be high. 
 HIV status was identified to be the associated factors of poor TB treatment outcome in 
Bahir-dar town governmental health institutions. 
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10. Recommendation 
 
Health institutions 
The health institution should be given specialattention and frequentand proper 
counseling for TB/HIV co-infected patients. 
Health facility should arrange mechanism to make convenient time for those who HIV 
positive patients arecoming for TB treatment. 
It is recommended that patients with TB/HIV confected be counseled on the need for 
adherence and commencing anti-retroviral medications properly which has the potential 
forpoor treatment outcome. 
Health professionals 
Proper counselingshould give in all possible reasons that causes for poor treatment 
outcome and also their possible solutions should discuss with patients even about 
his/her personal problem. 
TB patients  
TB patients especially HIV infected patients have to take their medication strictly on 
time for a given period of time and consult if any problem happens instead of interrupt.  
Researchers 
Theresearcher better to conducted prospective cohort study by including more 
variables in their study. 
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12. Annex 
Annex I: Data compilation checklist 
 
Facility level information  
 
Name of the Health facility: ___________date of data collection 
Ser .No Variables  Response Remark  
1 Address of the 
patient 
  
2 sex 1.male 
2.female 
 
3 age                      (yr)  
4 Residence 1.urban 
2.rural 
 
5 Base line weight                        (kg)  
6 Follow up weight (at 
end of intensive 
phase) 
                        (kg)  
7 Patient category 1.new 
2relapse 
3.failure 
4.default 
 
 
8 Disease category 1.pulmonary positive 
TB 
2.pulmonarynegativeTB 
3.Extra pulmonary TB 
 
9 Treatment started                  month  
10 HIV status 1.reactive 
2.non reactive 
3.unknown 
 
11 Drug in continuous 
phase  
1.EH 
2. RH 
3.(RH)E 
 
12 Treatment out come 1.cured 
2. completed 
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3. loss to follow  
4. died 
5. failure 
13 Health institution 1.health center 
2.hospital 
 
14 Health center 1.urban 
2.rural 
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